Literature DB >> 29431873

Blood-brain barrier and its function during inflammation and autoimmunity.

Sandip Ashok Sonar1, Girdhari Lal1.   

Abstract

The blood-brain barrier (BBB) is an important physiologic barrier that separates CNS from soluble inflammatory mediators and effector immune cells from peripheral circulation. The optimum function of the BBB is necessary for the homeostasis, maintenance, and proper neuronal function. The clinical and experimental findings have shown that BBB dysfunction is an early hallmark of various neurologic disorders ranging from inflammatory autoimmune, neurodegenerative, and traumatic diseases to neuroinvasive infections. Significant progress has been made in the understanding of the regulation of BBB function under homeostatic and neuroinflammatory conditions. Several neurologic disease-modifying drugs have shown to improve the BBB function. However, they have a broad-acting immunomodulatory function and can increase the risk of life-threatening infections. The recent development of in vitro multicomponent 3-dimensional BBB models coupled with fluidics chamber as well as a cell-type specific reporter and knockout mice gave a new boost to our understanding of the dynamics of the BBB. In the review, we discuss the current understanding of BBB composition and recent findings that illustrate the critical regulatory elements of the BBB function under physiologic and inflammatory conditions, and also suggested the strategies to control BBB structure and function. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  CNS; autoimmunity; blood-brain barriers; endothelial cells; neuroinflammation

Mesh:

Year:  2018        PMID: 29431873     DOI: 10.1002/JLB.1RU1117-428R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  26 in total

1.  A Retro-orbital Sinus Injection Mouse Model to Study Early Events and Reorganization of the Astrocytic Network during Pneumococcal Meningitis.

Authors:  Chakir Bello; Martine Cohen-Salmon; Guy Tran Van Nhieu
Journal:  Bio Protoc       Date:  2021-12-05

Review 2.  Neuroinflammation and immunoregulation in glioblastoma and brain metastases: Recent developments in imaging approaches.

Authors:  Rafael Roesler; Simone Afonso Dini; Gustavo R Isolan
Journal:  Clin Exp Immunol       Date:  2021-10-08       Impact factor: 4.330

Review 3.  Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders.

Authors:  Hema Kumari Alajangi; Mandeep Kaur; Akanksha Sharma; Sumedh Rana; Shipali Thakur; Mary Chatterjee; Neha Singla; Pradeep Kumar Jaiswal; Gurpal Singh; Ravi Pratap Barnwal
Journal:  Mol Brain       Date:  2022-06-01       Impact factor: 4.399

Review 4.  Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments.

Authors:  Mahmoud S Alghamri; Brandon L McClellan; Carson S Hartlage; Santiago Haase; Syed Mohd Faisal; Rohit Thalla; Ali Dabaja; Kaushik Banerjee; Stephen V Carney; Anzar A Mujeeb; Michael R Olin; James J Moon; Anna Schwendeman; Pedro R Lowenstein; Maria G Castro
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.988

Review 5.  The Complex Interactions Between Obesity, Metabolism and the Brain.

Authors:  Romina María Uranga; Jeffrey Neil Keller
Journal:  Front Neurosci       Date:  2019-05-24       Impact factor: 4.677

Review 6.  Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?

Authors:  Robb Wesselingh; Helmut Butzkueven; Katherine Buzzard; David Tarlinton; Terence J O'Brien; Mastura Monif
Journal:  Front Immunol       Date:  2019-09-10       Impact factor: 7.561

Review 7.  The Importance and Control of Low-Grade Inflammation Due to Damage of Cellular Barrier Systems That May Lead to Systemic Inflammation.

Authors:  Cecilia Rönnbäck; Elisabeth Hansson
Journal:  Front Neurol       Date:  2019-05-29       Impact factor: 4.003

8.  Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses.

Authors:  Ning Yuan; Yu Chen; Yan Xia; Jiacheng Dai; Chunyu Liu
Journal:  Transl Psychiatry       Date:  2019-09-18       Impact factor: 6.222

9.  Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer's Disease.

Authors:  Puneet Talwar; Suman Kushwaha; Renu Gupta; Rachna Agarwal
Journal:  Front Aging Neurosci       Date:  2019-10-23       Impact factor: 5.750

10.  Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.

Authors:  Chen Qiao; Qian Zhang; Qingling Jiang; Ting Zhang; Miaomiao Chen; Yi Fan; Jianhua Ding; Ming Lu; Gang Hu
Journal:  J Neuroinflammation       Date:  2018-07-02       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.